Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Grnhousegarbageon Sep 17, 2017 12:53am
98 Views
Post# 26705997

RE:Maricann is hard to analyze

RE:Maricann is hard to analyze
i unboxed you this so you can check it our later since it seems you have the sense to look into something before you dismiss it but ill share the articles and pr's here to https://www.cantechletter.com/2017/08/maricann-group-buy-despite-cfo-departure-canaccord-genuity/ this one shows a pic of phase 1 completed by Oct 2017 faze 2 started q4 2017 $5.00pt, https://m.marketwired.com/press-release/maricann-group-inc-enters-into-letter-of-intent-cnsx-mari-2230462.htm this one says first 20,000kg to come online early 2018 next 35,000kg by end 2018. https://globenewswire.com/news-release/2017/05/24/995709/0/en/Maricann-Laying-Down-Foundations-For-More-Growth.html this one state's that they will have an overall 817,000 sqft of grow space planned but not yet funded phase 3. Here's the best one I read on Germany https://globenewswire.com/news-release/2017/05/04/978706/0/en/Maricann-Secures-42-500-000-Non-Dilutive-Financing-for-Further-German-Expansion.html 400,000 sqft funded and outdoor hemp farm for cbd. This one reiterated the plan for a total 817,000 sqft https://www.simcoereformer.ca/2017/05/25/major-expansion-underway-at-langton-marijuana-operation. So it looks like 517,000 sqft out of the 817 is funded and will be operational in 2018 in Canada, then a fully funded 400,000 sqft German facility + hemp farm so 917,000 sqft international grow space + hemp farm FUNDED so far
Bullboard Posts